| Income Statement |
| Total Revenue | 10.13M |
|
| Revenues (USD) | 10.13M |
| Cost of Revenue | 4.30M |
| Gross Profit | 5.83M |
| Operating Expenses | 138.79M |
| Research and Development Expense | 91.74M |
| Selling, General and Administrative Expense | 47.05M |
| Operating Income | -132.96M |
| Interest Expense | 3.62M |
| Income Tax Expense | 216.00K |
| Net Income | -122.31M |
| Net Income Common Stock | -122.31M |
| Net Income Common Stock (USD) | -122.31M |
| Consolidated Income | -122.31M |
| Earnings per Basic Share | -0.53 |
| Earnings per Basic Share (USD) | -0.53 |
| Earnings per Diluted Share | -0.53 |
| Earning Before Interest & Taxes (EBIT) | -118.48M |
| Earning Before Interest & Taxes (USD) | -118.48M |
| Weighted Average Shares | 229.75M |
| Balance Sheet |
| Cash and Equivalents | 1.59B |
| Cash and Equivalents (USD) | 1.59B |
| Trade and Non-Trade Receivables | 6.43M |
| Current Assets | 1.62B |
| Property, Plant & Equipment Net | 388.81M |
| Total Assets | 2.01B |
| Debt Current | 8.76M |
| Total Debt | 204.54M |
| Current Liabilities | 75.86M |
| Debt Non-Current | 195.78M |
| Total Liabilities | 287.85M |
| Accumulated Retained Earnings (Deficit) | -2.04B |
| Accumulated Other Comprehensive Income | -87.00K |
| Shareholders Equity | 1.73B |
| Shareholders Equity (USD) | 1.73B |
| Assets Non-Current | 392.28M |
| Total Debt (USD) | 204.54M |
| Deferred Revenue | 17.14M |
| Liabilities Non-Current | 211.99M |
| Trade and Non-Trade Payables | 22.41M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 6.15M |
| Net Cash Flow from Financing | -1.25M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -120.82M |
| Capital Expenditure | -24.18M |
| Issuance (Purchase) of Equity Shares | 755.00K |
| Issuance (Repayment) of Debt Securities | -1.45M |
| Net Cash Flow from Investing | -24.18M |
| Net Cash Flow from Operations | -95.36M |
| Effect of Exchange Rate Changes on Cash | -41.00K |
| Share Based Compensation | 23.42M |